One Health | Totality of Evidence

“Operation Warp Speed” announced

On May 15, 2020, following March 2, 2020 discussions with pharmaceutical executives, President Trump announced a U.S. public-private partnership, the Operation Warp Speed Vaccine Initiative (OWSVI), to accelerate the development, manufacture, and distribution of COVID-19 vaccines, therapeutics, and diagnostics collectively known as countermeasures. With the aim of delivering 300 million doses of a safe, effective vaccine for the entire population of the United States with an effective vaccine “before the end of the year.” [1, 2, 3, 4, 5, 6] "President Trump's vision for a vaccine by January 2021 will be one of the greatest scientific and humanitarian accomplishments in history, and this is the team that can get it done," said HHS Secretary Alex Azar. OWS is headed by ex GSK's & ex Moderna's director Dr Moncef Slaoui, [7] with projects led by: Vaccines: Peter Marks, M.D., Ph.D., Director of the FDA's Center for Biologics Evaluation and Research. Therapeutics: Janet Woodcock, M.D., Director of the FDA's Center for Drug Evaluation and Research. Diagnostics: Bruce Tromberg, Ph.D., Director of the NIH's National Institute of Biomedical Imaging and Bioengineering. At this point Dr Anthony Fauci is not confident a vaccine will be effective. A warp speed vaccine could be deadly. Eleven..> READ MORE

COVID-19 vaccine developers have a problem – not enough sick people

As early as May 22, 2020 the lack of infectious cases of COVID-19 was identified by Adrien Hill from Oxford's Jenner institute when he said to Science mag "...we're beginning to run out of good trial sites to do vaccine efficacy studies—even the U.S. is plateauing," ...People are going to fight for that site to get the vaccine tested before it runs out." The disappearance of Ebola cases in November 2015 was a major problem for vaccine developers! Then on June 10, 2020 the Washington Post reported that Oxford University officials who were rushing to "develop coronavirus vaccines are alerting governments, health officials and shareholders" that declining numbers of new infections may be getting too small to quickly determine whether vaccines work! "Even as new cases are growing worldwide, transmission rates are falling in Britain, China and many of the hardest-hit regions in the United States — the three countries that have experimental vaccines ready to move into large-scale human testing in June, July and August." Volunteers need to be exposed to someone infected with the virus to determine if the vaccine works.

International Finance Facility for Immunisation (IFFIm) begins

In November 2004 the United Kingdom treasury and France announce their commitment to launch an International Finance Facility for Immunisation (IFFIm) - a pilot that would apply the principles of the broader IFF on a smaller scale to the immunisation sector. The International Finance Facility (IFF) starting January 2003, was inspired to provide development assistance funds for the United Nations 2015 Millennium Development Goals (MDG) to end global poverty. [1] In his speech in May 2005 addressing the World Health Assembly, Bill Gates mentioned the International Financing Facility for Immunizations which was "[p]roposed by the United Kingdom, with support pledged by France, Germany, Sweden, and Italy." Gates went on to say that "this initiative would provide developing countries with the reliable funding they need, year after year, to buy vaccines, which gives the private sector the market incentive to make them and deliver them. Market forces will work for poor people only if governments put up the funds to create a market." IFFIm is a international development institution and vital component of GAVI’s capital structure. The IFFIm is designed to accelerate the availability of funds to be used for health and immunisation programmes through the GAVI Alliance (GAVI) in 70..> READ MORE

Masks

Following are links to "mask or not to mask" information! Do they work and are they detrimental to health? This is an aggregation of some of the scientific evidence, articles and opinion supporting "masks-don't-work" when it comes to stopping infection…

15 May 2022Masks

WHO R&D Blueprint for action to prevent epidemics

Spurred by the West Africa Ebola epidemic, and "at the request of its 194 Member States", in May 2015, "the World Health Organization (WHO) convened a broad coalition of experts to develop an R&D Blueprint for Action to Prevent Epidemics". A year later, at the May 24, 2016 World Health Assembly (WHA), Members States welcomed the development of the R&D Blueprint" or Health Emergencies Program. All because infectious disease outbreaks are "inevitable" due to more "frequent travel, globalized trade and greater interconnectedness between countries." [2] The R&D Blueprint is a global strategy and preparedness plan that allows the rapid activation of research and development activities during epidemics. Its aim is to fast-track the availability of effective tests, vaccines and medicines that can be used to save lives and avert large scale crises. The R&D Blueprint uses a list of identified priority diseases and an unknown “Disease X”. For each disease an R&D roadmap is created, followed by target product profiles. This is then used to guide the response to outbreaks in both urgent action and in developing ways to improve the global response for future epidemics. On December 10, 2015 the WHO released its first (of what will be an..> READ MORE

WHO partners with the Wellcome Trust

On May 15, 2019 the World Health Organisation (WHO) announced the formation of a partnership with the Wellcome Trust, a non-state actor. The partnership is focused "on three broad areas of work: health emergencies and epidemic preparedness, anti-microbial resistance and supporting the acceleration of health-related Sustainable Development Goals (SDGs) through research, innovation and data." [2] "Epidemic preparedness is key for both organizations. As part of a joint initiative with the UK’s Department for International Development, Wellcome is one of the partners providing funding for WHO’s Research and Development (R&D) Blueprint activities." Endorsed at the World Health Assembly in May 2016 the R&D Blueprint “is a global strategy and preparedness plan that allows the rapid activation of research and development activities during epidemics" with the aim "to fast-track the availability of effective tests, vaccines and medicines that can be used to save lives and avert large scale crisis." [1, 3]

Computer model fraudulently shows unvaccinated spreading COVID-19

The Canadian media picks up on the conclusions of a scientific paper published in a Canadian journal on April 25, 2022, that allegedly concludes from computer modelling that unvaccinated people increase COVID-19 risk of transmission, compared to the vaccinated. BUT... Dr Byram Bridle in his substack article walks through how a simple change to just one "assumption" entered in to the mathematical model "completely reverses the conclusions of the paper". "Now the ‘unvaccinated’ are serving as a protective buffer for the ‘vaccinated.’" How could such a paper get through peer review and be published? Mathematical models (that generally have not been made public) have been used in South Australia [1, 2] and globally by Public Health to shape COVID-19 policy, their outputs are only as accurate as the inputs! One change to the computer model parameters took the unvaccinated from "dangerous" to "heros"!

US passes Bayh-Dole Act: Government funded scientists can now own patent rights

On December 12, 1980 the Patent and Trademark Law Amendments Act otherwise known as the Bayh–Dole Act passed into law in the United States. It is legislation dealing with intellectual property arising from federal government-funded research. Bayh-Dole permits universities to lay claim to all new ideas made in labs and research centers backed by federal funding—taxpayers’ money, instead of allegedly laying dormant when patents are assigned to the federal government. [1] In short Federal officials can profit from patents in the specialties for which they are hired using tax-payer funds. [6] "The idea was simple and straightforward. Create a single set of rules for all federal funding agencies to grant ownership of inventions to the universities and researchers that created them. With schools and researchers given the freedom to negotiate their license terms, more ideas would start to migrate from the lab to the market and in turn, provide economic growth." “Consider the fact that each year, NIH doles out $32 billion in grants to approximately 56,000 grantees". The NIH and it's department directors control who receives that funding - they control/direct where "innovation" can occur! Scientists could then license-out their patents to private companies, such as pharmaceutical companies if..> READ MORE

Dr Fauci and Dr Rajeev Venkayya push for a vaccine-only solution

By March 30, 2020, Dr Anthony Fauci is focused on vaccines as the way out of the COVID-19 pandemic, and already alluding to this being an annual "cycle". Around this same time Dr. Rajeev Venkayya, who has a vast history with vaccines [2, 3, 4, 5, 6, 7, 8, 9, 10, 11], including with President Bush, was on the phone call with Jeffrey Tucker [12, 13, 14] when when pressed about where the virus would go if lockdowns were implemented, he said "there will be a vaccine." Tucker noted at the time that "it would be a medical miracle never before seen to have a shot for a coronavirus that was sterilizing against wild type and all inevitable mutations, and to do it in a reasonable time so that society and economy had not completely fallen apart." [1] Note Fauci also emphasizes that Randomised Control Trials (RCT) can "prove" drugs work as opposed to "maybe they're going to work". What happens if the experts use a sub-lethal dose of a drug in a RCT (compared to the dose used by frontline doctors), this doesn't prove the drug is in effective, it just proves the drug has no mortality benefit at..> READ MORE

CDC release their PCR test to diagnose COVID-19

On Monday, February 3, 2020, CDC submitted an Emergency Use Authorization (EUA) their own product package to the U.S. Food and Drug Administration (FDA) to expedite FDA permitted use in the United States." This is to "authorize the use of unapproved, but potentially life-saving medical or diagnostic products during a public health emergency." The next day on February 4, 2020, the FDA issued the EUA and the CDC release their "CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-RCR Diagnostic Panel" which is "intended for the presumptive qualitative detection of nucleic acid from the 2019-nCoV...Positive results are indicative of active infection with 2019-nCoV but do not rule out bacterial infection or co-infection with other viruses." During the following 21 days after release of the CDC "exclusive" kit, "performance issues were identified related to a problem in the manufacturing of one of the reagents which led to laboratories not being able to verify the test performance." By then the virus had spread across the country. The CDC test kit fiasco had hindered the public health response to the virus. Which in May 2021 a FOIA revealed that the tests were "poorly designed and came with erroneous instructions that made it doubly difficult for labs..> READ MORE